Jane Street’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.3M | Buy |
223,615
+136,505
| +157% | +$23.9M | 0.01% | 1171 |
|
|
2025
Q4 | $14.8M | Sell |
87,110
-186,202
| -68% | -$28.5M | ﹤0.01% | 1876 |
|
|
2025
Q3 | $36M | Buy |
273,312
+230,960
| +545% | +$27.7M | 0.01% | 1145 |
|
|
2025
Q2 | $4.49M | Sell |
42,352
-173,866
| -80% | -$18.9M | ﹤0.01% | 3141 |
|
|
2025
Q1 | $26.8M | Buy |
216,218
+182,986
| +551% | +$23.9M | 0.01% | 1068 |
|
|
2024
Q4 | $4.09M | Sell |
33,232
-99,190
| -75% | -$11.7M | ﹤0.01% | 2947 |
|
|
2024
Q3 | $14.8M | Sell |
132,422
-81,569
| -38% | -$8.94M | ﹤0.01% | 1524 |
|
|
2024
Q2 | $22.8M | Buy |
213,991
+94,322
| +79% | +$10.4M | 0.01% | 1206 |
|
|
2024
Q1 | $14.4M | Sell |
119,669
-158,721
| -57% | -$19.4M | ﹤0.01% | 1470 |
|
|
2023
Q4 | $34.2M | Buy |
278,390
+191,530
| +221% | +$23.9M | 0.01% | 884 |
|
|
2023
Q3 | $11.2M | Buy |
86,860
+48,374
| +126% | +$6.45M | ﹤0.01% | 1656 |
|
|
2023
Q2 | $4.77M | Buy |
38,486
+21,414
| +125% | +$2.88M | ﹤0.01% | 2807 |
|
|
2023
Q1 | $2.5M | Sell |
17,072
-49,088
| -74% | -$7.26M | ﹤0.01% | 3447 |
|
|
2022
Q4 | $10.5M | Buy |
66,160
+61,410
| +1,293% | +$9M | ﹤0.01% | 1564 |
|
|
2022
Q3 | $634K | Sell |
4,750
-10,379
| -69% | -$1.58M | ﹤0.01% | 6243 |
|
|
2022
Q2 | $2.36M | Sell |
15,129
-31,523
| -68% | -$4.85M | ﹤0.01% | 3848 |
|
|
2022
Q1 | $7.26M | Buy |
46,652
+24,775
| +113% | +$3.6M | ﹤0.01% | 2447 |
|
|
2021
Q4 | $2.79M | Sell |
21,877
-56,593
| -72% | -$7.44M | ﹤0.01% | 3816 |
|
|
2021
Q3 | $10.2M | Buy |
78,470
+55,418
| +240% | +$8.37M | ﹤0.01% | 1778 |
|
|
2021
Q2 | $4.09M | Buy |
23,052
+12,766
| +124% | +$2.21M | ﹤0.01% | 3001 |
|
|
2021
Q1 | $1.69M | Sell |
10,286
-77,370
| -88% | -$12.7M | ﹤0.01% | 4356 |
|
|
2020
Q4 | $14.5M | Buy |
87,656
+61,161
| +231% | +$9.11M | 0.01% | 1111 |
|
|
2020
Q3 | $3.78M | Sell |
26,495
-24,981
| -49% | -$3.1M | ﹤0.01% | 2173 |
|
|
2020
Q2 | $5.68M | Buy |
51,476
+48,630
| +1,709% | +$5.38M | ﹤0.01% | 1708 |
|
|
2020
Q1 | $284K | Sell |
2,846
-1,073
| -27% | -$139K | ﹤0.01% | 4267 |
|
|
2019
Q4 | $585K | Sell |
3,919
-2,753
| -41% | -$375K | ﹤0.01% | 3495 |
|
|
2019
Q3 | $855K | Buy |
6,672
+5,101
| +325% | +$684K | ﹤0.01% | 2827 |
|
|
2019
Q2 | $224K | Sell |
1,571
-7,665
| -83% | -$1.03M | ﹤0.01% | 4574 |
|
|
2019
Q1 | $1.32M | Buy |
9,236
+5,485
| +146% | +$715K | ﹤0.01% | 2487 |
|
|
2018
Q4 | $465K | Buy |
+3,751
| New | +$556K | ﹤0.01% | 3542 |
|
|
2018
Q2 | – | Sell |
-1,628
| Closed | -$266K | – | 5298 |
|
|
2018
Q1 | $246K | Buy |
+1,628
| New | +$239K | ﹤0.01% | 4240 |
|
|
2017
Q4 | – | Sell |
-2,569
| Closed | -$376K | – | 4901 |
|
|
2017
Q3 | $376K | Sell |
2,569
-9,487
| -79% | -$1.43M | ﹤0.01% | 3433 |
|
|
2017
Q2 | $1.88M | Buy |
12,056
+5,924
| +97% | +$906K | 0.01% | 1552 |
|
|
2017
Q1 | $890K | Sell |
6,132
-1,944
| -24% | -$253K | ﹤0.01% | 2194 |
|
|
2016
Q4 | $881K | Buy |
8,076
+5,975
| +284% | +$666K | ﹤0.01% | 2224 |
|
|
2016
Q3 | $255K | Sell |
2,101
-2,487
| -54% | -$335K | ﹤0.01% | 3461 |
|
|
2016
Q2 | $648K | Sell |
4,588
-2,432
| -35% | -$359K | ﹤0.01% | 2484 |
|
|
2016
Q1 | $916K | Buy |
7,020
+1,371
| +24% | +$171K | 0.01% | 1929 |
|
|
2015
Q4 | $794K | Sell |
5,649
-5,119
| -48% | -$709K | ﹤0.01% | 1988 |
|
|
2015
Q3 | $1.43M | Buy |
10,768
+5,433
| +102% | +$935K | 0.01% | 1281 |
|
|
2015
Q2 | $939K | Buy |
+5,335
| New | +$958K | 0.01% | 1626 |
|
|
2015
Q1 | – | Sell |
-1,539
| Closed | -$264K | – | 3319 |
|
|
2014
Q4 | $252K | Buy |
+1,539
| New | +$255K | ﹤0.01% | 2028 |
|
|
2014
Q2 | – | Sell |
-18,791
| Closed | -$2.61M | – | 2853 |
|
|
2014
Q1 | $2.61M | Buy |
18,791
+17,191
| +1,074% | +$2.59M | 0.03% | 449 |
|
|
2013
Q4 | $202K | Sell |
1,600
-12,794
| -89% | -$1.32M | ﹤0.01% | 2017 |
|
|
2013
Q3 | $1.32M | Sell |
14,394
-6,206
| -30% | -$501K | 0.02% | 854 |
|
|
2013
Q2 | $1.42M | Buy |
+20,600
| New | +$1.26M | 0.02% | 642 |
|
Other funds holding JAZZ
VPM
VCM
EC
Jane Street's JAZZ Position: Q1 2026 in Review
Jane Street increased its Jazz Pharmaceuticals (JAZZ) stake by 157% in Q1 2026, buying an estimated $23.9M and bringing the position to 223,615 shares worth $42.3M. The position accounts for 0.01% of the portfolio, ranked #1171.
Jane Street first reported a position in JAZZ in Q2 2013 and has held it in 46 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Jane Street held 223,615 shares of Jazz Pharmaceuticals worth $42.3M as of Q1 2026.
- Jane Street bought 136,505 Jazz Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
- Jazz Pharmaceuticals made up 0.01% of Jane Street's portfolio in Q1 2026, its #1171 holding.
- Jane Street first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.